Effects of an Inhibitor of Poly(ADP-Ribose) Polymerase, Desmethylselegiline, Trientine, and Lipoic Acid in Transgenic ALS Mice

The development of transgenic mouse models of amyotrophic lateral sclerosis (ALS) allows the testing of neuroprotective agents. We evaluated the effects of five agents in transgenic mice with the G93A Cu,Zn superoxide dismutase mutation. A novel inhibitor of poly(ADP-ribose) polymerase showed no effects on survival. Desmethylselegiline and CGP3466 are agents that exert antiapoptotic effects in vitro by preventing nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase. They had no significant effects on survival in the G93A mice. Trientine, a copper chelator, produced a modest significant increase in survival. Similarly administration of lipoic acid in the diet produced a significant improvement in survival. These results therefore provide evidence for potential therapeutic effects of copper chelators and lipoic acid in the treatment of ALS.

[1]  P. Stieg,et al.  Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. , 2000, Science.

[2]  J. Warter,et al.  Prevention of mutant SOD1 motoneuron degeneration by copper chelators in vitro. , 2000, Journal of neurobiology.

[3]  W. Tatton,et al.  Reduced apoptosis after nerve growth factor and serum withdrawal: conversion of tetrameric glyceraldehyde-3-phosphate dehydrogenase to a dimer. , 2000, Molecular pharmacology.

[4]  J S Beckman,et al.  Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase. , 1999, Science.

[5]  L. Packer,et al.  Comparison of the effect of α-lipoic acid and α-tocopherol supplementation on measures of oxidative stress , 1999 .

[6]  D. Chuang,et al.  Involvement of Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) and p53 in Neuronal Apoptosis: Evidence That GAPDH Is Upregulated by p53 , 1999, The Journal of Neuroscience.

[7]  M. Lynch,et al.  Age-related changes in LTP and antioxidant defenses are reversed by an alpha-lipoic acid-enriched diet. , 1999, Neurobiology of aging.

[8]  D. Schiffer,et al.  Lack of apoptosis in mice with ALS , 1999, Nature Medicine.

[9]  D. Guastella,et al.  Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[10]  S. Sakoda,et al.  Benefit of a combined treatment with trientine and ascorbate in familial amyotrophic lateral sclerosis model mice , 1999, Neuroscience Letters.

[11]  B. Ames,et al.  (R)‐α‐Lipoic acid‐supplemented old rats have improved mitochondrial function, decreased oxidative damage, and increased metabolic rate , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  L. Bruijn,et al.  Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. , 1998, Science.

[13]  M. Moskowitz,et al.  Protective effects of 5-iodo-6-amino-1,2-benzopyrone, an inhibitor of poly(ADP-ribose) synthetase against peroxynitrite-induced glial damage and stroke development. , 1998, European journal of pharmacology.

[14]  D. Chuang,et al.  Nuclear localization of overexpressed glyceraldehyde-3-phosphate dehydrogenase in cultured cerebellar neurons undergoing apoptosis. , 1998, Molecular pharmacology.

[15]  S. Cuzzocrea,et al.  Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[16]  P. Fürst,et al.  Glyceraldehyde-3-phosphate Dehydrogenase, the Putative Target of the Antiapoptotic Compounds CGP 3466 andR-(−)-Deprenyl* , 1998, The Journal of Biological Chemistry.

[17]  C. Olanow,et al.  Deprenyl and desmethylselegiline protect mesencephalic neurons from toxicity induced by glutathione depletion. , 1998, The Journal of pharmacology and experimental therapeutics.

[18]  P. Hake,et al.  Suppression of experimental allergic encephalomyelitis by administration of 5-IODO-6-Amino-1,2,benzopyrone. A novel inhibitor of poly (ADP-ribose) synthetase , 1998 .

[19]  B. Diamond,et al.  Selegiline is ineffective in a collaborative double-blind, placebo-controlled trial for treatment of amyotrophic lateral sclerosis. , 1998, Archives of neurology.

[20]  S. Snyder,et al.  Glyceraldehyde-3-phosphate dehydrogenase: nuclear translocation participates in neuronal and nonneuronal cell death. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[21]  S. Snyder,et al.  Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia , 1997, Nature Medicine.

[22]  M. Gurney,et al.  The Copper Chelator d‐Penicillamine Delays Onset of Disease and Extends Survival in a Transgenic Mouse Model of Familial Amyotrophic Lateral Sclerosis , 1997, The European journal of neuroscience.

[23]  D. Borchelt,et al.  ALS-Linked SOD1 Mutant G85R Mediates Damage to Astrocytes and Promotes Rapidly Progressive Disease with SOD1-Containing Inclusions , 1997, Neuron.

[24]  C. Olanow,et al.  l‐(−)‐Desmethylselegiline, a Metabolite of Selegiline [l‐(−)‐Deprenyl], Protects Mesencephalic Dopamine Neurons from Excitotoxicity In Vitro , 1997, Journal of neurochemistry.

[25]  V. Ravindranath,et al.  α-Lipoic acid protects against reperfusion injury following cerebral ischemia in rats , 1996, Brain Research.

[26]  J. Krieglstein,et al.  Neuroprotective effects of α-lipoic acid and its enantiomers demonstrated in rodent models of focal cerebral ischemia , 1996, Neuropharmacology.

[27]  M. Gurney,et al.  Benefit of vitamin E, riluzole, and gababapentin in a transgenic model of familial amyotrophic lateral sclerosis , 1996, Annals of neurology.

[28]  D. Bredesen,et al.  Altered Reactivity of Superoxide Dismutase in Familial Amyotrophic Lateral Sclerosis , 1996, Science.

[29]  B. Halliwell,et al.  Protection against peroxynitrite‐dependent tyrosine nitration and α 1‐antiproteinase inactivation by oxidized and reduced lipoic acid , 1996, FEBS letters.

[30]  D. Borchelt,et al.  An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria , 1995, Neuron.

[31]  Robert H. Brown,et al.  Amyotrophic lateral sclerosis: Recent insights from genetics and transgenic mice , 1995, Cell.

[32]  R. Mason,et al.  Hydroxyl radical formation from cuprous ion and hydrogen peroxide: a spin-trapping study. , 1995, Archives of biochemistry and biophysics.

[33]  M. Gurney,et al.  Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. , 1994, Science.

[34]  M. Carson,et al.  ALS, SOD and peroxynitrite , 1993, Nature.

[35]  J. Haines,et al.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.